CDK Inhibitors : Cell Cycle Regulators and Beyond

First identified as cell cycle inhibitors mediating the growth inhibitory cues of upstream signaling pathways, the cyclin-CDK inhibitors of the Cip/Kip family p21Cip1, p27Kip1, and p57Kip2 have emerged as multifaceted proteins with functions beyond cell cycle regulation. In addition to regulating the cell cycle, Cip/Kip proteins play important roles in apoptosis, transcriptional regulation, cell fate determination, cell migration and cytoskeletal dynamics. A complex phosphorylation network modulates Cip/Kip protein functions by altering their subcellular localization, protein-protein interactions, and stability. These functions are essential for the maintenance of normal cell and tissue homeostasis, in processes ranging from embryonic development to tumor suppression.

[1]  Y. Yoneda,et al.  14‐3‐3 suppresses the nuclear localization of threonine 157‐phosphorylated p27Kip1 , 2004 .

[2]  A. Hall,et al.  Rho GTPases in cell biology , 2002, Nature.

[3]  K. Münger,et al.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. , 1997, Genes & development.

[4]  James M. Roberts,et al.  IS023 Cleavage of p21^ and p27^ Mediates Apoptosis in Endothelial Cells Through Activation of Cdk2: Role of a Caspase-3-like Caspase Cascade , 1998 .

[5]  A. Iavarone,et al.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.

[6]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[7]  T. Mukai,et al.  Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer , 2006, Cytogenetic and Genome Research.

[8]  Louise Izatt,et al.  Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  J. Slingerland,et al.  PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest , 2002, Nature Medicine.

[10]  R. Bast,et al.  Subcellular Localization of p 27 kip 1 Expression Predicts Poor Prognosis in Human Ovarian Cancer , 2005 .

[11]  T. Tsuruo,et al.  Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization* , 2003, Journal of Biological Chemistry.

[12]  J. Kench,et al.  Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. , 2001, Cancer research.

[13]  O. Bachs,et al.  Binding of Calmodulin to the Carboxy-Terminal Region of p21 Induces Nuclear Accumulation via Inhibition of Protein Kinase C-Mediated Phosphorylation of Ser153 , 2005, Molecular and Cellular Biology.

[14]  E. Sahai,et al.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. , 2003, Cancer cell.

[15]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[16]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[17]  Keiji Tanaka,et al.  p57Kip2 Regulates Actin Dynamics by Binding and Translocating LIM-kinase 1 to the Nucleus* , 2003, Journal of Biological Chemistry.

[18]  F. Gosselet,et al.  BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes. , 2007, Cellular signalling.

[19]  M. Surani,et al.  Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7 , 2007, BMC Developmental Biology.

[20]  O. Bachs,et al.  The Protein SET Regulates the Inhibitory Effect of p21Cip1 on Cyclin E-Cyclin-dependent Kinase 2 Activity* , 1999, The Journal of Biological Chemistry.

[21]  Pumin Zhang,et al.  p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. , 2006, Developmental biology.

[22]  O. Bachs,et al.  The SET Protein Regulates G2/M Transition by Modulating Cyclin B-Cyclin-dependent Kinase 1 Activity* , 2003, The Journal of Biological Chemistry.

[23]  M. Pagano,et al.  Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions , 2003, Molecular and Cellular Biology.

[24]  K. Münger,et al.  The human papillomavirus E 7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p 21 Cip 1-mediated inhibition of cdk 2 , 1997 .

[25]  B. Vanhaesebroeck,et al.  The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. , 2007, The EMBO journal.

[26]  H. Yoshikawa,et al.  Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. , 2004, Neuroscience.

[27]  M. Hoshino,et al.  Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration , 2006, Nature Cell Biology.

[28]  B. Joseph,et al.  The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway , 2007, Cell Death and Differentiation.

[29]  P. Leder,et al.  Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Fukushima,et al.  New p57KIP2 mutations in Beckwith-Wiedemann syndrome , 1997, Human Genetics.

[31]  Y. Yoneda,et al.  14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). , 2004, The EMBO journal.

[32]  M. Lisanti,et al.  Cyclin D1 induction of cellular migration requires p27(KIP1). , 2006, Cancer research.

[33]  T. Mukai,et al.  Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome , 1999, Human Genetics.

[34]  K. Nakayama,et al.  The Cyclin-dependent Kinase Inhibitors p57 and p27 Regulate Neuronal Migration in the Developing Mouse Neocortex* , 2007, Journal of Biological Chemistry.

[35]  M. Pagano,et al.  Regulation of the Cdk inhibitor p27 and its deregulation in cancer , 2000, Journal of cellular physiology.

[36]  J. Massagué,et al.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. , 1995, Cancer research.

[37]  近藤 征史 Selective maternal-allele loss in human lung cancers of the maternally expressed p57[KIP2] gene at 11p15.5 , 1998 .

[38]  C. Marshall,et al.  Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 , 1998, Nature.

[39]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[40]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[41]  田中 啓之 Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2005 .

[42]  M. Barbacid,et al.  Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors , 2000, Biological chemistry.

[43]  Vikram Devgan,et al.  p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. , 2005, Genes & development.

[44]  A. Feinberg,et al.  Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. , 1997, American journal of human genetics.

[45]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[46]  M. Serrano,et al.  Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. , 2001, Cancer research.

[47]  C. Cordon-Cardo,et al.  Somatic cell type specific gene transfer reveals a tumor-promoting function for p21Waf1/Cip1 , 2007, The EMBO journal.

[48]  Stanley N Cohen,et al.  Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Kerbel,et al.  Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.

[50]  S. Blain,et al.  Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.

[51]  N. Perkins,et al.  A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation , 2000, Molecular and Cellular Biology.

[52]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[53]  A. Koff,et al.  Rho Activity Can Alter the Translation of p27 mRNA and Is Important for RasV12-induced Transformation in a Manner Dependent on p27 Status* , 2002, The Journal of Biological Chemistry.

[54]  H. Yoshikawa,et al.  Cytoplasmic p21Cip1/WAF1 enhances axonal regeneration and functional recovery after spinal cord injury in rats , 2004, Neuroscience.

[55]  J. Priess,et al.  Cell polarity and gastrulation in C. elegans. , 2002, Development.

[56]  A. Gillenwater,et al.  Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  James M. Roberts,et al.  Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. , 2007, Genes & development.

[58]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[59]  M. Miura,et al.  Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.

[60]  M. Serrano,et al.  Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice , 2004, Oncogene.

[61]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[62]  L. Di Marcotullio,et al.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis , 2001, The EMBO journal.

[63]  James M. Roberts,et al.  Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.

[64]  K. Nakayama,et al.  p57KIP2 Modulates Stress-activated Signaling by Inhibiting c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase* , 2003, Journal of Biological Chemistry.

[65]  J. Baldassare,et al.  RhoA Stimulates p27Kip Degradation through Its Regulation of Cyclin E/CDK2 Activity* , 1999, The Journal of Biological Chemistry.

[66]  R. Bast,et al.  Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[68]  L. Hengst,et al.  p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.

[69]  H. Gascan,et al.  Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21 WAF1/CIP1/SDI1 * , 2000, The Journal of Biological Chemistry.

[70]  A. Philpott,et al.  The cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus , 2003, Development.

[71]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[72]  I. Roninson,et al.  Tumor cell senescence in cancer treatment. , 2003, Cancer research.

[73]  L. Hengst,et al.  CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. , 2003, Molecular biology of the cell.

[74]  M. Leibovitch,et al.  Stabilization of MyoD by Direct Binding to p57Kip2 * , 2000, The Journal of Biological Chemistry.

[75]  H. Yoshikawa,et al.  Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2002, The Journal of cell biology.

[76]  Natalie A. Lissy,et al.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.

[77]  J. Diehl,et al.  p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export* , 2002, The Journal of Biological Chemistry.

[78]  W. El-Deiry,et al.  Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity , 2005, Molecular and Cellular Biology.

[79]  L. Hengst,et al.  p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding , 2004, Nature Structural &Molecular Biology.

[80]  M. Serrano,et al.  Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma , 2006, Oncogene.

[81]  I. Roninson Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.

[82]  B. Tycko,et al.  Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. , 1997, American journal of human genetics.

[83]  T. Lyngbye,et al.  [Beckwith-Wiedemann syndrome]. , 1985, Ugeskrift for laeger.

[84]  H. Yoshikawa,et al.  Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21 cip1/waf1/sdi1 in DNA Replication and Transcription* , 2000, The Journal of Biological Chemistry.

[85]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[86]  E. Nabel,et al.  The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication , 2005, FEBS letters.

[87]  James M. Roberts,et al.  [p27Kip1 independently promotes neuronal differentiation and migration in the cerebral cortex]. , 2006, Bulletin et memoires de l'Academie royale de medecine de Belgique.

[88]  I. Herskowitz,et al.  The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating. , 1998, Science.

[89]  C. Cordon-Cardo,et al.  p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[90]  James M. Roberts,et al.  Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors? , 2004, Nature Reviews Cancer.

[91]  Alan Hall,et al.  Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement , 1999, The Journal of cell biology.

[92]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[93]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[94]  Frederick Y. Wu,et al.  Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. , 2006, Cancer research.

[95]  D. Mann,et al.  The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability , 2006, Cell cycle.

[96]  R. Bronson,et al.  Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[97]  A. Feinberg,et al.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[98]  D. Cheresh,et al.  Bifurcation of Cell Migratory and Proliferative Signaling by the Adaptor Protein Shc , 1999, The Journal of cell biology.

[99]  P. Pandolfi,et al.  Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.

[100]  S. Iguchi-Ariga,et al.  TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 Kinase* , 2000, The Journal of Biological Chemistry.

[101]  P. Soloway,et al.  Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1 , 2002, Nature Genetics.

[102]  B. Vanhaesebroeck,et al.  The p110δ isoform of PI 3‐kinase negatively controls RhoA and PTEN , 2007 .

[103]  M. Frey,et al.  Epidermal Growth Factor-stimulated Intestinal Epithelial Cell Migration Requires Src Family Kinase-dependent p38 MAPK Signaling* , 2004, Journal of Biological Chemistry.

[104]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[105]  Keith Burridge,et al.  RhoA is required for monocyte tail retraction during transendothelial migration , 2001, The Journal of cell biology.

[106]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[107]  Erik Sahai,et al.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.

[108]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[109]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[110]  James M. Roberts,et al.  p27Kip1 modulates cell migration through the regulation of RhoA activation. , 2004, Genes & development.

[111]  B. Stillman,et al.  Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. , 1997, Genes & development.

[112]  K. Welte,et al.  Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. , 2006, Blood.

[113]  Yong Lin,et al.  A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[114]  E. Pérez-Payá,et al.  The Structural Plasticity of the C Terminus of p21Cip1 is a Determinant for Target Protein Recognition , 2003, Chembiochem : a European journal of chemical biology.

[115]  M. Hung,et al.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.

[116]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[117]  A. Lenferink,et al.  ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells , 2002, Molecular and Cellular Biology.

[118]  R. DePinho,et al.  Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[119]  James M. Roberts,et al.  The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury , 1998, Nature Medicine.

[120]  C. Cordon-Cardo,et al.  p27 as a target for cancer therapeutics. , 2003, Cancer cell.

[121]  M. Toyota,et al.  Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors , 2002, Oncogene.

[122]  E. Brambilla,et al.  The yin and the yang of p27Kip1 as a target for cancer therapy , 2004, European Respiratory Journal.

[123]  James M. Roberts,et al.  A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. , 2006, Genes & development.

[124]  H. Höfler,et al.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans , 2006, Proceedings of the National Academy of Sciences.

[125]  R. Maione,et al.  p57Kip2 is induced by MyoD through a p73-dependent pathway. , 2006, Journal of molecular biology.

[126]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[127]  C. Stewart,et al.  Induction of p57KIP2 expression by p73β , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[128]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[129]  Giovanni Vanni Frajese,et al.  miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.

[130]  F. Ragione,et al.  p27Kip1 Metabolism: A Fascinating Labyrinth , 2007, Cell cycle.

[131]  J. Adkins,et al.  Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2 , 2002, Proteins.

[132]  J. Massagué,et al.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.

[133]  E. Choi,et al.  A non-enzymatic p21 protein inhibitor of stress-activated protein kinases , 1996, Nature.

[134]  L. Delavaine,et al.  Control of E2F activity by p21Waf1/Cip1 , 1999, Oncogene.

[135]  D. Helfman,et al.  Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway* , 2004, Journal of Biological Chemistry.

[136]  A. Gartel,et al.  Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.

[137]  M. Schwartz,et al.  Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.

[138]  V. Godfrey,et al.  Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity , 2000, Molecular and Cellular Biology.

[139]  S. Elledge,et al.  Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. , 1996, Oncogene.

[140]  S. Toyooka,et al.  Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. , 2004, Oncology reports.

[141]  E. Sahai,et al.  Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility , 2001, The EMBO journal.

[142]  R. Perris The extracellular matrix in neural crest-cell migration , 1997, Trends in Neurosciences.

[143]  Reuven Agami,et al.  Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .

[144]  M. Roussel,et al.  Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. Barbacid,et al.  Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.

[146]  Shile Huang,et al.  Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). , 2003, Molecular cell.

[147]  Chen-feng Qi,et al.  Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. , 2006, Leukemia research.

[148]  B. Datnow,et al.  Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. , 2007, Cancer research.

[149]  Richard W. Kriwacki,et al.  Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.

[150]  Matthias Peter,et al.  Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating , 2000, Nature Cell Biology.